1887

Abstract

Summary

Representative isolates of from 15 cystic fibrosis (CF) patients attending the Respiratory Unit of Alder Hey Childrens’ Hospital were investigated by SDS-PAGE of whole-cell polypeptides and by pyrolysis mass spectroscopy (PMS). SDS-PAGE was less discriminatory than PMS. Eleven isolates were indistinguishable by PMS and considered to represent re-isolates of an endemic strain; four isolates were distinct from this group, and from one another. was first isolated on the unit in July 1989 from a patient who had attended a UK selection meeting for a Canadian CF camp. A ward and outpatient segregation policy was introduced, but colonisation of further patients occurred. In August 1991, the Adult CF Association recommended that all social activities involving colonised patients should cease. This, and an increased awareness amongst older CF patients of the risks of person-to-person transmission, was associated with a marked decline in new cases. Social activity and hospital admissions were compared for colonised patients during the year before colonisation with and matched patients who did not acquire the endemic strain. This showed a significantly higher attendance at CF social events for colonised patients, but no significant association between colonisation and hospital admission. These results are strong indirect evidence that transmission of occurs through social contact outside the hospital environment.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-41-2-106
1994-08-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/41/2/medmicro-41-2-106.html?itemId=/content/journal/jmm/10.1099/00222615-41-2-106&mimeType=html&fmt=ahah

References

  1. Isles A, MacLusky I, Corey M. et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984; 104:206–210
    [Google Scholar]
  2. Tablan OC, Chorba TL, Schidlow DV. et al. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr 1985; 107:382–387
    [Google Scholar]
  3. Editorial Pseudomonas cepacia—more than a harmless commensal?. Lancet 1992; 339:1385–1386
    [Google Scholar]
  4. Smith DL, Smith EG, Gumery LB, Stableforth DE. Pseudomonas cepacia infection in cystic fibrosis. Lancet 1992; 339:252
    [Google Scholar]
  5. LiPuma JJ, Dasen SE, Nielson DW, Stern RC, Stull TL. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 1990; 336:1094–1096
    [Google Scholar]
  6. Govan JRW, Brown PH, Maddison J. et al. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993; 342:15–19
    [Google Scholar]
  7. Smith DL, Gumery LB, Smith EG, Stableforth DE, Kaufmann ME, Pitt TL. Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: Evidence of person-to-person transmission. J Clin Microbiol 1993; 31:3017–3022
    [Google Scholar]
  8. Working party of the British Society of Antimicrobial Chemotherapy A guide to sensitivity testing. J Antimicrob Chemother 1991; 27:Suppl D1–50
    [Google Scholar]
  9. Aries RE, Gutteridge CS, Ottley TW. Evaluation of a low cost, automated pyrolysis mass spectrometer. J Anal Appl Pyrolysis 1986; 9:81–98
    [Google Scholar]
  10. Corkill JE, Deveney J, Pratt J. et al. Effect of pH and CO2 on in vitro susceptibility of Pseudomonas cepacia to β-lactams. Pediatr Res 1994 (in press)
    [Google Scholar]
  11. Magee JT, Yuang J, Ryley HC. Typing of clinical and environmental Pseudomonas cepacia by pyrolysis mass spectroscopy. Escobar H, Baquero F, Suarez L. (eds) Clinical ecology of cystic fibrosis Amsterdam: Excerpta Medica; 199389–93
    [Google Scholar]
  12. Sisson PR, Freeman R, Lightfoot NF. Pyrolysis mass spectroscopy of micro-organisms. PHLS Microbiol Digest 1992; 2:65–68
    [Google Scholar]
  13. Orr K, Gould FK, Sisson PR, Lightfoot NF, . Freeman R, Burdess D. Rapid inter-strain comparison by pyrolysis mass spectroscopy in nosocomial infection with Xanthomonas maltophilia. J Hosp Infect 1991; 17:187–195
    [Google Scholar]
  14. Sisson PR, Freeman R, Gould FK, Lightfoot NF. Strain differentiation of nosocomial isolates of Pseudomonas aeruginosa by pyrolysis mass spectroscopy. J Hosp infect 1991; 19:137–140
    [Google Scholar]
  15. Nelson JW, Doherty CJ, Brown PH, Greening AP, Kaufmann ME, Govan JRW. Pseudomonas cepacia in inpatients with cystic fibrosis. Lancet 1991; 338:1525
    [Google Scholar]
  16. Burdge DR, Nakielna EM, Noble MA. Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis. Infect Control Hosp Epidemiol 1993; 14:127–130
    [Google Scholar]
  17. Millar-Jones L, Pauli A, Saunders Z, Goodchild MC. Transmission of Pseudomonas cepacia among cystic fibrosis patients. Lancet 1992; 340:491
    [Google Scholar]
  18. Report of the Working Party of the Cystic Fibrosis Trust’s Pseudomonas cepacia (Pc) Group Cystic fibrosis statement on Pseudomonas cepacia.August 1993
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-41-2-106
Loading
/content/journal/jmm/10.1099/00222615-41-2-106
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error